CME Group (CME) Revenue — Quarter Ended Sep 30, 2024
Revenue increased in the current quarter. The growth was supported by higher operating cash flows as noted in the filing.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Revenue increased in the current quarter. The growth was supported by higher operating cash flows as noted in the filing.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.6B
Revenue reported for this quarter.
Quarter-over-quarter
+3.4%
Change from the immediately preceding quarter.
Year-over-year
+18.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $1.4B | +19.2% |
| Mar 31, 2024 | $1.5B | +3.2% |
| Jun 30, 2024 | $1.5B | +12.7% |
| Sep 30, 2024 | $1.6B | +18.4% |
Revenue performance
Revenue rose compared to the immediately preceding quarter. The filing attributes the increase in operating cash flows partly to higher revenues.
Quarterly comparison
Revenue was also higher than the same quarter one year earlier. The filing notes that net cash from operations increased in the first nine months of the current year versus the prior year period, largely due to higher revenues.
What to watch
Monitor whether revenue growth can sustain given the reliance on operating cash flow improvements noted in the filing.